Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Other Non-Current Assets (2011 - 2026)

Updated

Vistagen Therapeutics (VTGN) reported Other Non-Current Assets of $392,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 16.9% from $472,000 a year earlier and down 0.3% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Other Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Other Non-Current Assets of $393,000, down 13.4% from FY2025.

  • Other Non-Current Assets has a five-year compound annual growth rate of 5.9% (FY2021 to FY2026).
  • By fiscal year, Other Non-Current Assets came in at $454,000 in FY2025 (-37.5%), $726,000 in FY2024 (+46.4%), $496,000 in FY2023 (+54.1%) and $321,800 in FY2022 (+9.1%).
  • Five-year quarterly Other Non-Current Assets spans a low of $321,600 in fiscal Q2 2022 and a high of $726,000 in fiscal Q4 2024.
  • Year over year, Other Non-Current Assets has now declined in each of the last six quarters, with an average decline of 3.7% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Assets in five years was fiscal Q1 2023 (growth of 69.6%); the low point was fiscal Q4 2025 (a decline of 37.5%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $393,000 (Q4 2026), $392,000 (Q3 2026) and $405,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - 392,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 392,000.00
Mar 31, 2026 393,000.00
Dec 31, 2025 392,000.00
Sep 30, 2025 405,000.00
Jun 30, 2025 472,000.00
Mar 31, 2025 454,000.00
Dec 31, 2024 477,000.00
Sep 30, 2024 498,000.00
Jun 30, 2024 518,000.00
Mar 31, 2024 726,000.00
Dec 31, 2023 325,700.00
Sep 30, 2023 362,000.00
Jun 30, 2023 522,100.00
Mar 31, 2023 496,000.00
Dec 31, 2022 411,400.00
Sep 30, 2022 411,400.00
Jun 30, 2022 381,200.00
Mar 31, 2022 321,800.00
Dec 31, 2021 321,800.00
Sep 30, 2021 321,600.00
API Access

Vistagen Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VTGN&period=max&api_key=YOUR_API_KEY